Where to buy eflornithine (IWILFIN) in the country and how to buy it

Eflornithine (IWILFIN) is a new anti-tumor drug mainly used to treat a variety of solid tumors and hematological malignancies. Its mechanism of action is to interfere with the synthesis of DNA and RNA in tumor cells, thereby inhibiting tumor proliferation and inducing apoptosis. Since the drug is a high-tech targeted drug and has not yet been approved for marketing in China, patients cannot purchase it directly through formal domestic channels.

Eflornithine tablets are not yet on the market in China, nor are they included in the medical insurance system, so they are not available in hospital pharmacies, pharmacies or domestic electronic drug platforms. This means that if domestic patients need to use the drug, they must obtain it through special overseas channels or clinical research projects, and strictly follow doctor's guidance and regulatory requirements.

In overseas markets, the original drug of eflornithine has been launched. The common specification is 192mg*100 tablets, and each box sells for about US$10,000. There are currently no generic drugs on the market. If patients consider obtaining drugs through overseas channels, they generally include: ordering directly from overseas pharmacies, obtaining them through clinical trial projects or international drug assistance programs. All routes require strict physician prescription and related procedures, as well as attention to transportation and storage conditions.

Since eflornithine is expensive and does not have medical insurance support in China, patients need to make financial and medication plans in advance. The price of overseas original drugs is about more than 10,000 US dollars per box, and there are currently no generic drugs that can reduce costs. Before use, you should fully consult a professional doctor to clarify the dosage, course of treatment and potential risks, and ensure that the drugs are purchased through formal and legal channels to ensure drug safety and legitimate rights and interests.

Reference link:https://www.drugs.com